Prestige Consumer Healthcare Inc. $PBH Stock Acquired by Leeward Investments LLC MA

Leeward Investments LLC MA lifted its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 20.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 526,609 shares of the company’s stock after buying an additional 88,693 shares during the quarter. Prestige Consumer Healthcare accounts for 1.2% of Leeward Investments LLC MA’s portfolio, making the stock its 16th biggest holding. Leeward Investments LLC MA’s holdings in Prestige Consumer Healthcare were worth $24,156,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of PBH. Barrow Hanley Mewhinney & Strauss LLC acquired a new position in Prestige Consumer Healthcare during the second quarter worth $30,000. Versant Capital Management Inc lifted its holdings in Prestige Consumer Healthcare by 47.9% in the second quarter. Versant Capital Management Inc now owns 726 shares of the company’s stock valued at $34,000 after acquiring an additional 235 shares during the period. Caitong International Asset Management Co. Ltd lifted its holdings in Prestige Consumer Healthcare by 69.8% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 574 shares of the company’s stock valued at $35,000 after acquiring an additional 236 shares during the period. Cornerstone Planning Group LLC acquired a new stake in Prestige Consumer Healthcare in the first quarter valued at $44,000. Finally, Global Retirement Partners LLC purchased a new stake in shares of Prestige Consumer Healthcare during the 2nd quarter worth $80,000. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Zacks Research raised shares of Prestige Consumer Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, September 30th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Prestige Consumer Healthcare in a report on Tuesday, September 22nd. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $67.67.

Prestige Consumer Healthcare Price Performance

Prestige Consumer Healthcare stock opened at $47.78 on Monday. Prestige Consumer Healthcare Inc. has a 52 week low of $42.62 and a 52 week high of $71.07. The company has a quick ratio of 1.99, a current ratio of 3.23 and a debt-to-equity ratio of 1.06. The firm’s 50-day simple moving average is $48.81 and its 200 day simple moving average is $50.09. The firm has a market capitalization of $2.26 billion, a PE ratio of 13.38, a P/E/G ratio of 1.50 and a beta of 0.34.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.98 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.09. Prestige Consumer Healthcare had a net margin of 15.57% and a return on equity of 11.39%. The firm had revenue of $265.71 million for the quarter, compared to analysts’ expectations of $253.02 million. During the same period in the prior year, the company earned $0.90 EPS. The firm’s revenue was up 6.5% on a year-over-year basis. Prestige Consumer Healthcare has set its FY 2027 guidance at 4.550-4.650 EPS. On average, equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.56 EPS for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc (NYSE: PBH) is a consumer healthcare company that develops, acquires, markets and distributes over-the-counter health and wellness products. Its portfolio is focused on established brands designed to address everyday healthcare needs, including digestive health, eye and ear care, oral care, pain relief, cold and allergy symptoms, feminine care and dermatological conditions.

The company’s brands include Dramamine and Bonine for motion-sickness relief; BC and Goody’s for pain relief; Clear Eyes and Murine for eye and ear care; Chloraseptic for sore-throat relief; Compound W for wart removal; Fleet for gastrointestinal health; and Summer’s Eve for feminine care.